48 reports

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes - Pipeline Review, H2 2020, provides an overview of the Type 1 Diabetes (Metabolic Disorders) pipeline landscape. Type 1 diabetes (T1D) is...

  • Type 1 Diabetes
  • Endocrine Disease
  • World

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes – Pipeline Review, H1 2020, provides an overview of the Type 1 Diabetes (Metabolic Disorders) pipeline landscape. Type 1 diabetes (T1D)...

  • Type 1 Diabetes
  • Endocrine Disease
  • World

Type ## Diabetes:

  • Type 1 Diabetes
  • World
  • Diabetes Prevalence
  • Prescription Drug Sales

Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H1, 2020 Summary Clinical trial report, “Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H1, 2020" provides an overview of Type 1 Diabetes (Juvenile Diabetes) Clinical trials scenario.This report provides top...

  • Clinical Trial
  • Type 1 Diabetes
  • World

The ongoing clinical trial research report- “2019 Type 1 Diabetes Ongoing Clinical Trials Study” analyzes the current scenario of all active Type 1 Diabetes trials across the world. The report presents top level analysis of global Type 1 Diabetes clinical trials across countries, companies and universities. It is designed to provide clear...

  • Type 1 Diabetes
  • Clinical Trial
  • World
  • APAC

Type ## Diabetes:

  • Therapy
  • Type 1 Diabetes
  • World
  • Diabetes Prevalence
  • Prescription Drug Sales

Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2018" provides an overview of Type 1 Diabetes (Juvenile Diabetes) clinical trials scenario.This report provides...

  • Clinical Trial
  • Type 1 Diabetes
  • World

Blood Glucose Device Market, Users Global Forecast, SMBG Components of 17 Countries (America, Europe, Asia & Pacific, MENA) & Companies According to International diabetes federation, in 2017, there are around 425 million of people living with diabetes in the world. Diabetes people all over the world...

  • Diabetes
  • Diabetes Monitoring
  • Patient Monitoring
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Insulin
  • World
  • China
  • Overweight Prevalence
  • Gross Domestic Product Per Capita

In 2015, L## Diagnostics, LLC was awarded research grant fund of USD ## from National Institute of Diabetes and Digestive and Kidney Diseases [NIH No: ##R##DK##-##] for the project entitled Therapeutic Inhibition of MIF in Type ## Diabetes".

  • Autoimmune Disease
  • Arthritis
  • Oncology
  • Type 1 Diabetes
  • Neurological Disorder
  • Prostate Cancer
  • Hypertension
  • Antimalarials
  • World
  • Pharmaceutical Exports
  • Drug Approval

Fusion Proteins to Agonize OX## and NOTCH## for Type ## Diabetes – Drug Profile

  • Monoclonal Antibody
  • Oncology
  • Therapy
  • Biopharmaceutical
  • Biotechnology
  • Type 1 Diabetes
  • Transplantation
  • World
  • Manufacturing Output

Drug to Agonize Aryl Hydrocarbon Receptor for Type ## Diabetes – Drug Profile

  • Therapy
  • Neurological Disorder
  • Dermatological Condition
  • Infectious Disease
  • Autoimmune Disease
  • Pharmaceutical
  • Oncology
  • Type 1 Diabetes
  • Biotechnology
  • World
  • Drug Approval
  • Medical Technology Density

Drug to Agonize Aryl Hydrocarbon Receptor for Type ## Diabetes – Drug Profile

  • Therapy
  • Neurological Disorder
  • Dermatological Condition
  • Pharmaceutical
  • Autoimmune Disease
  • Oncology
  • Type 1 Diabetes
  • Biotechnology
  • World
  • Drug Approval
  • Medical Technology Density

In 2015, L## Diagnostics, LLC was awarded research grant fund of USD ## from National Institute of Diabetes and Digestive and Kidney Diseases [NIH No: ##R##DK##-##] for the project entitled Therapeutic Inhibition of MIF in Type ## Diabetes".

  • Immunotherapy
  • Type 1 Diabetes
  • Prostate Cancer
  • Oncology
  • Pharmaceutical
  • Antimalarials
  • World
  • Drug Approval
  • Diagnostic Imaging Density

Drug to Agonize Aryl Hydrocarbon Receptor for Type ## Diabetes – Drug Profile

  • Oncology
  • Type 1 Diabetes
  • Pharmaceutical
  • Autoimmune Disease
  • Neurological Disorder
  • Transplantation
  • World

Fusion Proteins to Agonize OX## and NOTCH## for Type ## Diabetes – Drug Profile

  • Monoclonal Antibody
  • Oncology
  • Transplantation
  • Type 1 Diabetes
  • World
  • Prescription Drug Sales
  • Drug Approval

This study covers the world outlook for type 1 diabetes mellitus (T1DM) treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the...

  • Type 1 Diabetes
  • World
  • Gross Domestic Product
  • Disposable Income

Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018 Summary Diabetes refers to a group of metabolic diseases that result from defects in insulin secretion, insulin action or both of these. Type I diabetes is an autoimmune disease in which the pancreas stops producing...

  • Insulin
  • Diabetes
  • Type 1 Diabetes

Cell Pouch System - Type ## Diabetes Mellitus

  • Clinical Trial
  • Type 1 Diabetes
  • World
  • Canada
  • North America
  • Medical Devices Sales

## Type ## Diabetes: Executive Summary

  • Type 1 Diabetes
  • World
  • United States
  • Canada
  • Japan
  • Diabetes Prevalence
  • Life Expectancy

In 2015, L## Diagnostics, LLC was awarded research grant fund of USD ## from National Institute of Diabetes and Digestive and Kidney Diseases [NIH No: ##R##DK##-##] for the project entitled Therapeutic Inhibition of MIF in Type ## Diabetes".

  • Immunotherapy
  • Type 1 Diabetes
  • World
  • Drug Approval

Type 1 Diabetes (Juvenile Diabetes) ongoing clinical trials report provides comprehensive analysis and trends in global Type 1 Diabetes (Juvenile Diabetes) disease clinical trials. The research work analyzes the ongoing Type 1 Diabetes (Juvenile Diabetes) clinical trial trends across countries and companies. The report focuses on drugs...

  • Type 1 Diabetes
  • World

Drug to Agonize Aryl Hydrocarbon Receptor for Type ## Diabetes – Drug Profile

  • Type 1 Diabetes
  • Pharmaceutical
  • Autoimmune Disease
  • Neurological Disorder
  • World

Novo Nordisk Enters Into R&D Agreement With Juvenile Diabetes Research Foundation For Type ## Diabetes

  • Type 1 Diabetes
  • United States
  • New York
  • Diabetes Prevalence

Feb ##: Orgenesis Approved for Euro ## Million European Grant for Further Development of Its Type ## Diabetes Program

  • Cell Therapy
  • Type 1 Diabetes
  • Pharmaceutical
  • Healthcare
  • Private Placement
  • Europe
  • Pharmaceutical Production
  • Birth Rate

This partnership enables SFC and JDRF to expand future therapy options for people with type ## diabetes (T##D).

  • Type 1 Diabetes
  • Medical Equipment
  • United States
  • Canada
  • New York
  • World
  • Denmark
  • Netherlands
  • Australia
  • Israel
  • APAC
  • Diabetes Prevalence
  • Direct Sales

##/##/2017: Autoantigen GAD-Vaccine is Safe for Children at High Risk for Developing Type ## Diabetes

  • Type 1 Diabetes
  • Diabetes
  • Vaccine
  • Pharmaceutical
  • Healthcare
  • United States
  • World
  • Vaccination Coverage

Sep ##: Study Advances Efforts to Screen All Children for Type I Diabetes

  • Diagnostics
  • Type 1 Diabetes
  • Biomarker
  • Prosthesis
  • Psychotic Disorder
  • Breast Cancer
  • Hepatitis
  • United States
  • World
  • North America
  • Diagnostic Imaging Density
  • Birth Rate

TOP-LINE PREVALENCE FOR TYPE ## DIABETES MELLITUS

  • Type 1 Diabetes
  • Spain
  • United Kingdom
  • United States
  • Italy
  • France
  • Germany
  • China
  • Russia
  • India
  • Canada
  • Japan
  • Brazil
  • Diabetes Prevalence
  • Diabetes Incidence

Maverick Type ## Diabetes (T##D) Assay Kit

  • Diagnostics
  • Arthritis
  • Biomarker
  • Type 1 Diabetes
  • Clinical Trial
  • Molecular Diagnostics
  • United States
  • Medical Devices Sales
  • Health Provider Density

Drug analysis: Farxiga

8770 10000 7800

Drug Overview Farxiga (dapagliflozin; AstraZeneca) is a member of the novel sodium-glucose cotransporter-2 (SGLT-2) inhibitor class. It is approved for the treatment of type 2 diabetes and currently in Phase III trials for the treatment of type 1 diabetes. SGLT-2 inhibitors do not target insulin secretion or...

  • Sodium-Glucose Co-Transporter 2 Inhibitor
  • Type 2 Diabetes
  • Type 1 Diabetes